Fine Organic Industries
- P/E
- 35.94
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 21.50%
- Debt to Equity
- 0.03
- EPS (TTM)
- ₹142.89
- Book Value
- ₹955.74
- Market Cap
- —
- P/E (TTM)
- 35.94
- P/B
- 5.37
- ROE
- 16.50%
- Dividend Yield
- 0.22%
- EBITDA
- ₹600 Cr
- 52W High
- ₹5,666.00
- 52W Low
- ₹3,856.00
- Day Range
- ₹5,020.00 – ₹5,150.00
- Volume
- 12,140
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,135.00 | 35.94 | ₹15,730 Cr | 5.37 | 0.22% | 16.50% | 21.50% | ₹2,472 Cr | ₹438 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Median 8 companies | ₹3,095.85 | 46.49 | ₹20,474 Cr | 5.71 | 0.23% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 72
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 34
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 31
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 90
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 63
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.5%
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 7 | 5 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Neutral
Key readings
- RSI (14)
- 47.22
- Neutral
- MACD (12,26,9)
- −37.41
- Bearish
- SMA (50)
- 5,215.23
- Bearish
- SMA (200)
- 4,807.49
- Bullish
As of
Analyst Rating
10 of 12 analysts rate Buy, 0 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +13.62% |
|---|---|
| 5Y | +15.87% |
| 3Y | −7.84% |
| 1Y | +4.28% |
| TTM | +7.06% |
Net profit
| 10Y | +18.56% |
|---|---|
| 5Y | +28.29% |
| 3Y | −12.29% |
| 1Y | +1.71% |
| TTM | +5.80% |
Operating cash flow
| 10Y | — |
|---|---|
| 5Y | +26.26% |
| 3Y | −3.93% |
| 1Y | +110.78% |
| TTM | — |
10Y: The statements do not go back far enough for this window.
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.83 pp |
|---|---|
| 5Y | +2.81 pp |
| 3Y | −7.13 pp |
| 1Y | −2.28 pp |
| TTM | 0.00 pp |
Revenue by year
| Mar 2017 | ₹778 Cr |
|---|---|
| Mar 2018 | ₹856 Cr |
| Mar 2019 | ₹1,060 Cr |
| Mar 2020 | ₹1,038 Cr |
| Mar 2021 | ₹1,133 Cr |
| Mar 2022 | ₹1,876 Cr |
| Mar 2023 | ₹3,023 Cr |
| Mar 2024 | ₹2,123 Cr |
| Mar 2025 | ₹2,269 Cr |
| Mar 2026 | ₹2,366 Cr |
Net profit by year
| Mar 2017 | ₹78.00 Cr |
|---|---|
| Mar 2018 | ₹95.00 Cr |
| Mar 2019 | ₹136 Cr |
| Mar 2020 | ₹165 Cr |
| Mar 2021 | ₹120 Cr |
| Mar 2022 | ₹260 Cr |
| Mar 2023 | ₹618 Cr |
| Mar 2024 | ₹412 Cr |
| Mar 2025 | ₹410 Cr |
| Mar 2026 | ₹417 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Fine Organic Industries Ltd trades at ₹5,102 as of 2026-10-28 with a market cap of ₹15,642.72 Cr and a PE of 35.71x. The company is virtually debt-free (debt-to-equity of 0.03) with a strong long-term ROE track record of 25% over 5 and 10 years, though recent growth in sales and profits has decelerated meaningfully from historical rates.
- Near-zero leverage with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience through economic cycles
- Strong long-term return on equity track record — 25% ROE over both 5-year and 10-year periods, indicating durable competitive advantages in oleochemical derivatives
- ROCE of 20.07% reflects efficient capital deployment and pricing power in a specialty chemicals niche with limited organised competition
- Compounded sales CAGR of 16% over 5 years and 14% over 10 years demonstrates a consistent long-term revenue growth trajectory
- Compounded profit CAGR of 28% over 5 years indicates strong operating leverage and margin expansion during growth phases
- Stock is trading roughly 10% below its 52-week high of ₹5,666 and about 32% above its 52-week low of ₹3,856, suggesting it has recovered well from recent lows
- TTM sales and profit growth have turned positive at 7% each, signalling a potential recovery from the 3-year decline in both revenue and earnings
- EPS TTM of ₹142.89 supports profitability even in what appears to be a trough phase relative to the company's historical growth rates
- PE TTM of 35.71x is elevated for a specialty chemicals company whose TTM sales and profit growth are only 7%, implying the stock prices in significantly faster future growth
- 3-year compounded sales CAGR of -8% and 3-year compounded profit CAGR of -13% indicate a prolonged period of revenue and earnings contraction
- Last year ROE has declined sharply to 16% from the 3-year average of 19% and the 5-year average of 25%, suggesting diminishing returns on equity
- Price-to-book ratio of 5.87x is rich, particularly when current ROE of 15.65% has compressed from historical levels, reducing the justification for a high PB multiple
- Dividend yield of just 0.22% offers negligible income return, meaning investors are entirely dependent on capital appreciation to generate returns
- 1-year stock CAGR of 18% has outpaced the underlying TTM earnings growth of 7%, suggesting the re-rating may have front-run the fundamental recovery
- 3-year stock CAGR of only 4% compared to broader market returns highlights extended underperformance, reflecting the earnings decline over the same period
- As a niche oleochemical player with a market cap of ₹15,642.72 Cr, the company faces concentration risk in a cyclical raw material environment tied to vegetable oil prices
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Fine Organic delivered a strong Q2FY27 with 42% profit growth, healthy margin expansion, and a dominant export mix. The ₹120 crore SEZ investment signals management confidence in medium-term demand. No material headwinds surfaced in recent coverage. The trend is clearly improving, though sustaining these margins amid global oleochemical price volatility will be worth monitoring.
- Net profit surges 42% YoY Nov 3
Standalone net profit rose 41.7% YoY to ₹135.14 crore in Q2FY27, signaling strong earnings momentum.
- EBITDA margin expansion Nov 3
Consolidated EBITDA margin improved to 25.4% in Q2FY27 from 22.6% in Q2FY26, a 280 bps expansion.
- ₹120 crore SEZ investment Nov 3
Board approved an additional ₹120 crore investment in its SEZ subsidiary, indicating confidence in future capacity needs.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 | 555 | 625 | 694 | 729 |
| Expenses | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 | 463 | 461 | 496 | 520 | 544 |
| Operating Profit | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 | 134 | 94 | 129 | 174 | — |
| OPM % | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% | 22% | 17% | 21% | 25% | — |
| Other Income | 14 | 17 | 17 | 22.83 | 24 | 22 | 25 | 26 | 47 | 21 | 21 | 35 | 24 | — |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 2 |
| Depreciation | 12 | 14 | 15 | 15 | 12 | 12.41 | 13 | 15 | 12 | 13 | 14 | 18 | 14 | 14 |
| PBT | 143 | 133 | 119 | 150 | 152 | 160 | 115 | 130 | 157 | 143 | 101 | 144 | 184 | 197 |
| Tax % | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% | 24% | 27% | 18% | 25% | 23% |
| Net Profit | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 | 74 | 117 | 138 | 152 |
| EPS (₹) | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.3 | 26.97 | 31.68 | 38.19 | 35.4 | 24.11 | 38.32 | 45.06 | — |
Sep 2026: from the results filed on 2 Nov 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,366 | 2,472 |
| Expenses | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,886 | 1,941 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 480 | 531 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 20% | 21% |
| Other Income | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 124 | 101 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 4 | 4 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 56 | 58 |
| PBT | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 556 | 543 | 569 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | 23% | — |
| Net Profit | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 417 | 438 |
| EPS (₹) | 158 | 161 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 202 | 134 | 134 | 136 | 143 |
| Div. Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% | 8% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,649 |
| Borrowings | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 68 |
| Other Liabilities | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 206 | 266 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 |
| Fixed Assets | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 388 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 64 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 38 |
| Other Assets | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,078 | 2,508 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 |
Cash Flow
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 | 430 |
| Investing | — | −16 | −52 | −93 | −85 | −40 | −32 | −128 | −396 | −675 | −430 |
| Financing | — | −55 | −17 | 92 | −37 | −41 | −68 | −69 | −59 | −35 | 0 |
| Net Cash Flow | — | −26 | −3 | 97 | 98 | 53 | −33 | 289 | 180 | −506 | −1 |
| Free Cash Flow | — | 34 | 13 | 5 | 146 | 88 | 6 | 405 | 549 | 77 | 288 |
| CFO/OP | — | 65 | 73 | 79 | 119 | 89 | 41 | 86 | 148 | 68 | 116 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 54 | 54 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 | 104 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 | 45 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 111 | 113 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 | 92 |
| ROCE % | — | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fine Organic Industries insights
63 extracted metrics across FY15–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Concall · May 2026PPT
- Concall · Mar 2026Transcript
- Concall · Feb 2026PPT
- Concall · Nov 2025PPT
- 19 May 2026
- 29 Sep 2025
- 16 Jul 2024
- 20 Jun 2023
- 18 Apr 2022
- 6 Apr 2021
- General announcements 3 Nov 2026
- General announcements 30 Oct 2026
Frequently Asked Questions about Fine Organic Industries
What does Fine Organic Industries Ltd do?
Where is Fine Organic Industries Ltd (FINEORG) listed?
Which sector does Fine Organic Industries Ltd belong to?
What is the PE ratio of Fine Organic Industries Ltd?
What is the 52-week high and low of Fine Organic Industries Ltd?
Does Fine Organic Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Fine Organic Industries Ltd?
Company Information
Fine Organic Industries is engaged in and outside India as manufacturers, processors, suppliers, distributors, dealers, importers, exporters of wide range of oleochemical-based additives used in foods, plastics, cosmetics, coatings and other specialty application in various industries.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FINEORG.md for Fine Organic Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.